2016 Annual General Meeting of Galenica Ltd.
Thursday, 28 April 2016, ↓ directly to download
88th Annual General Meeting of Galenica Ltd.:
Shareholders approve all proposals submitted by the Board of Directors
At the 88th Annual General Meeting of Galenica Ltd. in Bern, shareholders approved all of the proposals submitted by the Board of Directors. The Annual General Meeting was attended by 386 shareholders, representing a total of 53% of the registered voting shares of Galenica Ltd.
The shareholders voted in favour of the proposals put forward by the Board of Directors on all items on the agenda: The Annual General Meeting approved the Annual Report and the 2015 Annual Financial Statements of Galenica Ltd. as well as the Consolidated Financial Statements of the Galenica Group for 2015 and discharged the members of the Board of Directors and the Corporate Executive Committee from liability for their activities in 2015. The Annual General Meeting also approved the proposal to renew the approved capital for a further two years.
Also approved was the dividend of CHF 18.00 (+20.0%, prior year: CHF 15.00) proposed by the Board of Directors, which will be paid to shareholders on 6 May 2016.
Galenica is a diversified Group active throughout the healthcare market which, among other activities, develops, manufactures and markets pharmaceutical products, runs pharmacies, provides logistical and database services and sets up networks. With its two Business units Vifor Pharma and Galenica Santé, the Galenica Group enjoys a leading position in all its core business activities. A large part of the Group’s income is generated by international operations. Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALN, security number 1,553,646).
Friday, 23 December 2016
Friday, 9 December 2016
Monday, 28 November 2016
Thursday, 6 October 2016
Friday, 2 September 2016
Head of Corporate Communications
Head Investor Relations